BioSpace News Archive

Deals

Aviragen Therapeutics Issues Letter to Stockholders

The letter urged stockholders to vote FOR the Company’s proposed merger with Vaxart at its Special Meeting of Stockholders on February 6, 2018.

January 24, 2018
·
17 min read
Biotech Bay

Neuspera Medical Announces Initial Close of $26M Series B Equity Financing

The $26M financing was led by 6 Dimensions Capital with all existing investors from Series A also participating including Action Potential Venture Capital and Windham Venture Partners.

January 24, 2018
·
3 min read
CAS Group Delivers Letter to the Stockholders of Aviragen

Digirad , East Hill Management Company, LLC and Thomas M. Clay, are significant stockholders of Aviragen, and collectively beneficially own in the aggregate approximately 8.3% of AVIR’s outstanding shares of common stock, delivered a letter to the stockholders of AVIR today.

January 24, 2018
·
16 min read
Business

Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories

Under the amended collaboration agreement, studies will be conducted to generate and evaluate semi-synthetic cytisine derivatives for potential use in multiple indications across addiction and neurological disorders.

January 24, 2018
·
5 min read
Business

Cardiovascular Systems Names Former Medtronic Exec as COO

Robb will report to Scott Ward, CSI Chairman, President and Chief Executive Officer.o

January 24, 2018
·
2 min read
Biotech Beach

Aerie Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Aerie today announced that it has priced its registered underwritten public offering of $75 million of shares of its common stock.

January 24, 2018
·
4 min read
Business

Inge Thulin Elected to Merck Board of Directors

Mr. Thulin will stand for election with the company’s other directors in connection with Merck’s Annual Meeting of Shareholders on May 22, 2018.

January 24, 2018
·
4 min read
RTI Surgical Release: Published Data Show Successful 24-Month Sacroiliac Joint Fusion and Pain Reduction with the SImmetry System

The data show SImmetry provides radiographically evident sacroiliac (SI) joint fusion as early as 12 months with higher fusion rates observed at 24 months, while effectively reducing pain in patients with SI joint disorders.

January 24, 2018
·
5 min read
CureVac Expands Intellectual Property Position That Significantly Improves Protein Expression for Its mRNA-Based Vaccines and Therapeutics

CureVac announced that the United States Patent and Trademark Office and the European Patent Office have granted or respectively intend to grant multiple composition of matter patents for CureVac’s mRNA technology.

January 24, 2018
·
3 min read
Policy

NIH Gets Into CRISPR/Cas9, Launches $190M Genome Editing Research Program

Somatic Cell Genome Editing aims to develop tools for safe and effective genome editing in humans.

January 24, 2018
·
3 min read